Abstract

DOMINGUEZ PEREZ, Rafael et al. Coronavirus disease 2019 (COVID-19) and pregnancy. Acta méd. Grupo Ángeles [online]. 2020, vol.18, n.4, pp.399-406.  Epub June 06, 2022. ISSN 1870-7203.  https://doi.org/10.35366/97267.

Coronavirus disease 2019 (COVID-19) is an emerging disease with a rapid increase in cases and deaths since its first identification in Wuhan, China, in December 2019. Amid a rapidly evolving outbreak that could have significant effects on our health and medical infrastructure, the particular needs of pregnant women should be included. The SARS-CoV-2 virus has been described as having a predilection for the ACE II receptor present in pneumocytes, enterocytes and at the placental. The placental condition could cause hypoperfusion and thrombosis; restriction on intrauterine growth and/or preterm birth. The most common symptoms in pregnant women with COVID-19 are fever, cough, muscle pain, dyspnoea and respiratory distress data. Diagnosis should be made by rt-PCR for SARS-CoV-2, in nasopharyngeal exudate and oropharyngeal. It is recommended that health workers caring for pregnant women strictly follow the recommended prevention measures. At present, there is no vaccine for this disease, however various drugs have been described that could be useful, taking into account the risk-benefit of each of these.

Keywords : Coronavirus; pregnancy; COVID-19.